Genetic variation at chromosome 8q24 in osteosarcoma cases and controls

Carcinogenesis

Volumn 31, Issue 8, 2010, Pages 1400-1404

  Mirabello, Lisa ^a   Berndt, Sonja I ^a   Seratti, Guillermo F ^a,b   Burdett, Laurie ^c   Yeager, Meredith ^c   Chowdhury, Salma ^c   Teshome, Kedest ^c   Uzoka, Arinze ^c   Douglass, Chester ^d   Hayes, Richard B ^e   Hoover, Robert N ^a   Savage, Sharon A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c SAIC FREDERICK INC   (United States)

^d HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^e NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CHROMOSOME 8Q; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GERM LINE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

BONE NEOPLASMS; CASE-CONTROL STUDIES; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; GENES, DOMINANT; GENES, RECESSIVE; GENETIC VARIATION; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MODELS, GENETIC; OSTEOSARCOMA; REFERENCE VALUES; REGRESSION ANALYSIS; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 77955395342     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq117     Document Type: Article

References (52)

1. Mirabello,L. et al. (2009) Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer, 115, 1531-1543.
2. Kager,L. et al. (2003) Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J. Clin. Oncol., 21, 2011-2018.
3. Longhi,A. et al. (2005) Height as a risk factor for osteosarcoma. J. Pediatr. Hematol. Oncol., 27, 314-318.
4. Fraumeni,J.F.Jr. (1967) Stature and malignant tumors of bone in childhood and adolescence. Cancer, 20, 967-973.
5. Troisi,R. et al. (2006) Perinatal factors, growth and development, and osteosarcoma risk. Br. J. Cancer, 95, 1603-1607.
6. Operskalski,E.A. et al. (1987) A case-control study of osteosarcoma in young persons. Am. J. Epidemiol., 126, 118-126.
7. Ruza,E. et al. (2003) Analysis of polymorphisms of the vitamin D receptor, estrogen receptor, and collagen Ialpha1 genes and their relationship with height in children with bone cancer. J. Pediatr. Hematol. Oncol., 25, 780-786.
8. Lindor,N.M. et al. (2008) Concise handbook of familial cancer susceptibility syndromes-second edition. J. Natl Cancer Inst. Monogr., 1-93.
9. Patio-Garcia,A. et al. (2000) Analysis of the human tumour necrosis factoralpha (TNFalpha) gene promoter polymorphisms in children with bone cancer. J. Med. Genet., 37, 789-792.
10. Savage,S.A. et al. (2007) Germ-line genetic variation of TP53 in osteosarcoma. Pediatr. Blood Cancer, 49, 28-33.
11. Savage,S.A. et al. (2007) Analysis of genes critical for growth regulation identifies Insulin-like Growth Factor 2 Receptor variations with possible functional significance as risk factors for osteosarcoma. Cancer Epidemiol. Biomarkers Prev., 16, 1667-1674.
12. Koshkina,N.V. et al. (2007) Exploratory analysis of Fas gene polymorphisms in pediatric osteosarcoma patients. J. Pediatr. Hematol. Oncol., 29, 815-821.
13. Toffoli,G. et al. (2009) Effect of TP53 Arg72Pro and MDM2 SNP309 polymorphisms on the risk of high-grade osteosarcoma development and survival. Clin. Cancer Res., 15, 3550-3556.
14. Gudmundsson,J. et al. (2007) Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat. Genet., 39, 631-637.
15. Yeager,M. et al. (2009) Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat. Genet., 41, 1055-1057.
16. Al Olama,A.A. et al. (2009) Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat. Genet., 41, 1058-1060.
17. Yeager,M. et al. (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet., 39, 645-649.
18. Savage,S.A. et al. (2007) The evidence for prostate cancer risk loci at 8q24 grows stronger. J. Natl Cancer Inst., 99, 1499-1501.
19. Fletcher,O. et al. (2008) Association of genetic variants at 8q24 with breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 17, 702-705.
20. Schumacher,F.R. et al. (2007) A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res., 67, 2951-2956.
21. Kiemeney,L.A. et al. (2008) Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat. Genet., 40, 1307-1312.
22. Tomlinson,I. et al. (2007) A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat. Genet., 39, 984-988.
23. Yeager,M. et al. (2008) Comprehensive resequence analysis of a 136 kb region of human chromosome 8q24 associated with prostate and colon cancers. Hum. Genet., 124, 161-170.
24. Tuupanen,S. et al. (2009) The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat. Genet., 41, 885-890.
25. Pomerantz,M.M. et al. (2009) Evaluation of the 8q24 prostate cancer risk locus and MYC expression. Cancer Res., 69, 5568-5574.
26. Pomerantz,M.M. et al. (2009) The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat. Genet., 41, 882-884.
27. Jia,L. et al. (2009) Functional enhancers at the gene-poor 8q24 cancerlinked locus. PLoS Genet., 5, e1000597.
28. Meyer,N. et al. (2008) Reflecting on 25 years with MYC. Nat. Rev. Cancer, 8, 976-990.
29. Stock,C. et al. (2000) Chromosomal regions involved in the pathogenesis of osteosarcomas. Genes Chromosomes Cancer, 28, 329-336.
30. Ladanyi,M. et al. (1993) Sporadic amplification of the MYC gene in human osteosarcomas. Diagn. Mol. Pathol., 2, 163-167.
31. Gamberi,G. et al. (1998) C-myc and c-fos in human osteosarcoma: prognostic value of mRNA and protein expression. Oncology, 55, 556-563.
32. Jain,M. et al. (2002) Sustained loss of a neoplastic phenotype by brief inactivation of MYC. Science, 297, 102-104.
33. Man,T.K. et al. (2004) Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma. BMC Cancer, 4, 45.
34. Selvarajah,S. et al. (2008) Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH. Cytogenet. Genome Res., 122, 5-15.
35. Gauderman,W.J. et al. (2006) QUANTO 1.1: a computer program for power and sample size calculations for genetic-epidemiology studies. Ref Type: Computer Program. Available from http://hydra.usc.edu/gxe.
36. Barrett,J.C. et al. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 21, 263-265.
37. Frazer,K.A. et al. (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature, 449, 851-861.
38. Klein,R.J. et al. (2005) Complement factor H polymorphism in age-related macular degeneration. Science, 308, 385-389.
39. Meyer,A. et al. (2009) Association of chromosomal locus 8q24 and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy. Urol. Oncol., 27, 373-376.
40. Gruber,S.B. et al. (2007) Genetic variation in 8q24 associated with risk of colorectal cancer. Cancer Biol. Ther., 6.
41. Poynter,J.N. et al. (2007) Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: results from the Colon Cancer Family Registry. Cancer Res., 67, 11128-11132.
42. Schafmayer,C. et al. (2009) Investigation of the colorectal cancer susceptibility region on chromosome 8q24.21 in a large German case-control sample. Int. J. Cancer, 124, 75-80.
43. Tenesa,A. et al. (2008) Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat. Genet., 40, 631-637.
44. Severi,G. et al. (2007) The common variant rs1447295 on chromosome 8q24 and prostate cancer risk: results from an Australian populationbased case-control study. Cancer Epidemiol. Biomarkers Prev., 16, 610-612.
45. Wang,L. et al. (2007) Two common chromosome 8q24 variants are associated with increased risk for prostate cancer. Cancer Res., 67, 2944-2950.
46. FitzGerald,L.M. et al. (2009) Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features. Clin. Cancer Res., 15, 3231-3237.
47. Haiman,C.A. et al. (2007) Multiple regions within 8q24 independently affect risk for prostate cancer. Nat. Genet., 39, 638-644.
48. Berndt,S.I. et al. (2008) Pooled analysis of genetic variation at chromosome 8q24 and colorectal neoplasia risk. Hum. Mol. Genet.
49. Edwards,A.O. et al. (2005) Complement factor H polymorphism and agerelated macular degeneration. Science, 308, 421-424.
50. Haines,J.L. et al. (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science, 308, 419-421.
51. Jakobsdottir,J. et al. (2005) Susceptibility genes for age-related maculopathy on chromosome 10q26. Am. J. Hum. Genet., 77, 389-407.
52. Schork,N.J. et al. (2009) Common vs. rare allele hypotheses for complex diseases. Curr. Opin. Genet. Dev., 19, 212-219.